Skip to main content
ARAY
NASDAQ Industrial Applications And Services

Accuray Lands $55M Rescue Package, Restructures Debt, and Overhauls Governance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.236
Mkt Cap
$27.469M
52W Low
$0.22
52W High
$2.1
52W Position info
7.0% above low
Off High info
89% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

ARAY is trading near its 52-week low of $0.22 (7.0% above the low) on light trading volume (0.3× avg).

Summary

Accuray announced a $55M recapitalization with existing lenders, exchanging $40M of debt for preferred stock and raising $15M in new cash. The deal includes new penny warrants, cancellation of old warrants, a covenant holiday, and a governance overhaul giving TCW board control, contingent on a reverse stock split and shareholder vote.


Key Events · Financing and Capital Events · ARAY

  • $55M Preferred Stock Financing

    A Securities Purchase Agreement was signed to sell 55,000 shares of Series A Convertible Preferred Stock for $55 million, consisting of $15 million in cash and the conversion of $40 million of existing debt. The preferred stock carries an 8% dividend, a liquidation preference, and converts at $0.50 per share (subject to reverse split adjustment).

  • Warrant Restructuring

    Investors received 15.3 million new penny warrants exercisable at $0.01 per share for 7 years. Simultaneously, 27.6 million existing warrants with exercise prices between $1.25 and $1.68 were cancelled, contingent on closing.

  • Debt Covenant Relief and Additional Liquidity

    Amendment No. 3 to the Financing Agreement provides a covenant holiday through December 31, 2027, modifies minimum liquidity requirements, and adds a $5 million Delayed Draw Term Loan facility. The revolving facility was converted to an asset-based structure.

  • Governance Overhaul and Board Control

    Two directors resigned, reducing the board to seven members. TCW gained the right to designate two directors and have representation on key board committees. The company must obtain TCW consent for major actions, including issuing senior securities or changing board size.


Analysis · ARAY · Industrial Applications And Services

Facing a delisting warning, material weaknesses, and withdrawn guidance, Accuray has secured a $55 million financing package from existing lenders. The arrangement delivers $15 million in fresh cash and converts $40 million of debt into preferred stock, immediately reducing leverage. In return, investors receive 15.3 million penny warrants while 27.6 million higher-priced warrants are cancelled, and they gain significant governance rights—including two board seats and veto power over major decisions. The transaction hinges on a reverse stock split and shareholder approval. If approved, it provides a critical liquidity runway and a covenant holiday through 2027, but at the cost of substantial dilution and ceding control to TCW. Should shareholder approval fail, the $15 million cash becomes additional debt with a $15 million penalty fee, worsening the balance sheet.

How filings like this one have moved

In the 30 days to Sep 11, 2026, 42.4% of the 517 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.47%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ARAY was trading at $0.24 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $27.5M. The 52-week trading range was $0.22 to $2.10. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ARAY - Latest Insights

ARAY
Sep 11, 2026, 9:55 AM EDT
Source: MFN by Modular Finance
Importance Score:
7
Price at Filing: $0.2558
Real-time Price: $0.248 info
Change: -$0.0078 (-3%) info
Market Cap: $29.621M info
ARAY
Aug 27, 2026, 4:02 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.2621
Real-time Price: $0.248 info
Change: -$0.0141 (-5%) info
Market Cap: $29.621M info
ARAY
Aug 24, 2026, 4:02 PM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $0.2716
Real-time Price: $0.248 info
Change: -$0.0236 (-9%) info
Market Cap: $29.621M info
ARAY
Aug 19, 2026, 4:05 PM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $0.3001
Real-time Price: $0.248 info
Change: -$0.0521 (-17%) info
Market Cap: $29.621M info
ARAY
Aug 19, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.3157
Real-time Price: $0.248 info
Change: -$0.0677 (-21%) info
Market Cap: $29.621M info